Financing priorities in global health lag behind the changing realities of lower- and lower-middle-income countries, where the noncommunicable disease burden is growing. Investment in the capabilities required to address NCDs will also benefit pandemic control efforts.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: